Related Experiment Video
Updated: Mar 8, 2026

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
The Juvenile Psoriatic Arthritis Cohort in the CARRA Registry: Clinical Characteristics, Classification, and Outcomes
Insights
Juvenile psoriatic arthritis (JPsA) patients may be divided into two groups based on age at onset. While objective symptoms improved, patient-reported outcomes did not, suggesting a need to unify JPsA and adult psoriatic arthritis classification criteria.
Area of Science:
- Rheumatology
- Pediatric Rheumatology
- Clinical Immunology
Background:
- Juvenile psoriatic arthritis (JPsA) is a complex condition requiring precise classification.
- Current classification criteria, including the International League of Associations for Rheumatology (ILAR) and Classification criteria for Psoriatic Arthritis (CASPAR), may not fully capture all pediatric cases.
Purpose of the Study:
- To analyze demographic and clinical features of children with JPsA.
- To compare JPsA patients classified by ILAR and CASPAR criteria.
- To investigate the relationship between age at disease onset and clinical presentation in JPsA.
Main Methods:
- Cross-sectional analysis of 361 children in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry.
- Stratification of patients by age at disease onset (≤ or > 4 years).
- Comparison of baseline and 1-year follow-up data using statistical tests.
Main Results:
- 72.02% of patients had symptom onset after 4 years of age, with male predominance and high enthesitis prevalence.
- Statistically significant improvements were observed in arthritis, dactylitis, enthesitis, psoriasis, sacroiliitis, and nail pitting at follow-up.
- Patients meeting CASPAR criteria but not ILAR criteria showed more enthesitis, sacroiliitis, inflammatory bowel disease, and uveitis, with less psoriasis.
Conclusions:
- JPsA patients can be divided into two clinical subgroups based on age at disease onset.
- Objective symptom improvement did not correlate with health questionnaire scores.
- Unifying adult and pediatric psoriatic arthritis classification criteria should be considered, as current pediatric criteria may not identify all children meeting adult criteria.
Objective:
Children with clinically diagnosed juvenile psoriatic arthritis (JPsA) who were enrolled in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry (CARRA-JPsA) were classified according to pediatric International League of Associations for Rheumatology (ILAR) and adult criteria [Classification criteria for Psoriatic Arthritis (CASPAR)]. Data on demographic and clinical features at baseline and 1-year followup were analyzed and compared.
Methods:
Cross-sectional analysis was performed of CARRA-JPsA patients enrolled between May 2010 and December 2013 and stratified according to age at disease onset (≤ or > 4 yrs). Features of patients fulfilling ILAR and CASPAR criteria were compared at baseline and followup using chi square, Fisher's exact, Mann-Whitney-McNemar, Wilcoxon signed rank, and t tests, as appropriate.
Results:
Among 361 children enrolled as CARRA-JPsA, 72.02% had symptom onset at > 4 years of age, with a male predominance and high prevalence of enthesitis. At followup, statistically significant improvements were reported in arthritis, dactylitis, enthesitis, psoriasis, sacroiliitis, and nail pitting, but not in health questionnaire (HQ) scores. Of the patients, 80.5% fulfilled ILAR criteria for JPsA. Fifty-two patients, whose disease fulfilled CASPAR criteria but had not been included in the JPsA cohort, manifested more enthesitis, sacroiliitis, inflammatory bowel disease and uveitis and less psoriasis.
Conclusion:
The data support division of patients with JPsA into 2 clinical subgroups, according to age at disease onset. Improvement in objective findings did not correlate with changes in HQ scores. Pediatric rheumatologists currently do not diagnose JPsA in all children whose disease manifestations meet CASPAR criteria. Unification of adult and pediatric PsA classification criteria warrants consideration.
Related Concept Videos
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History

